bioRxiv preprint doi: https://doi.org/10.1101/2020.07.01.182618; this version posted September 3, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow
device compared to a nucleocapsid-only device
Christian A. Linares, Felicity Ryan, Samuel E. Moses

The authors have withdrawn their manuscript whilst they perform additional experiments to test
some of their conclusions further. Therefore, the authors do not wish this work to be cited as
reference for the project. If you have any questions, please contact the corresponding author.

